Tokyo, Japan

Yuri Fujisawa

This inventor holds 1 USPTO granted patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuri Fujisawa. Retrieved from https://idiyas.com/inventor/yuri-fujisawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yuri Fujisawa

Introduction

Yuri Fujisawa is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. Her work has led to advancements that may have important implications for medical science.

Latest Patents

Yuri Fujisawa holds a patent for a compound known as a 1,3-dihydro-2H-indol-2-one derivative. This compound is expressed by a specific formula where various groups and atoms are defined, including halogen atoms and alkyl groups. The compound exhibits antagonistic activity against the arginine-vasopressin V1 receptor, making it a promising candidate for further pharmaceutical development. She has 1 patent to her name.

Career Highlights

Fujisawa is currently employed at Taisho Pharmaceutical Co., Ltd., where she continues her research and development efforts. Her innovative work in the pharmaceutical industry has positioned her as a key figure in her field.

Collaborations

Yuri has collaborated with notable colleagues such as Toshihito Kumagai and Takeshi Kuwada. These partnerships have enhanced her research capabilities and contributed to her success in patenting innovative compounds.

Conclusion

Yuri Fujisawa's contributions to the field of pharmaceuticals through her innovative patent work highlight her importance as an inventor. Her ongoing research promises to yield further advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…